NDUFA4 Antibody

What applications are NDUFA4 antibodies suitable for?

NDUFA4 antibodies are validated for multiple experimental applications:

Most commercially available antibodies have been validated with human samples, with many also showing cross-reactivity with mouse and rat NDUFA4 .

How can I verify NDUFA4 antibody specificity in my experiments?

To ensure specificity of NDUFA4 antibodies:

• Positive controls: Use cell lines known to express NDUFA4, such as HepG2 or 293T cells which have been validated as positive samples .

• Knockout validation: Where possible, compare samples from wild-type and NDUFA4 knockout models. Research has demonstrated undetectable NDUFA4 protein levels in tissue samples from patients with homozygous NDUFA4 mutations .

• Expected molecular weight: Confirm detection at the expected molecular weight (~9-10 kDa). The observed MW is typically around 10 kDa though the calculated MW is 9 kDa .

• Subcellular localization: Verify mitochondrial localization using co-localization with mitochondrial markers. Immunocytochemistry studies have confirmed mitochondrial localization of NDUFA4 using MitoTracker staining .

How do detergent conditions affect NDUFA4 detection in native protein complexes?

Detergent concentration critically affects the detection of NDUFA4 as part of complex IV. Research has demonstrated that:

• Dissociation of NDUFA4 from complex IV occurs when >0.08% n-dodecyl β-D-maltoside (DDM) is used for mitochondrial membrane protein extraction .

• For analyzing NDUFA4 as part of the COX holoenzyme, ≤0.08% DDM should be used .

• In standard protocols used to purify complex IV for crystallization purposes, higher concentrations (>1.5%) of DDM disrupt the interaction of NDUFA4 with complex IV .

This explains why NDUFA4 was not initially identified as a COX subunit, as standard purification protocols likely caused its dissociation from the complex. For researchers studying NDUFA4 in native complexes, these detergent conditions are crucial methodological considerations .

What are the recommended sample preparation methods for detecting NDUFA4 in different experimental systems?

For optimal NDUFA4 detection:

Western blot analysis of denaturing gels:

• Prepare mitochondrial-enriched protein pellets (10 μg recommended)

• For native complexes: extract using ≤0.08% DDM to maintain NDUFA4 association with complex IV

• Use standard SDS-PAGE protocols with appropriate percentage gels (15-18% recommended due to low molecular weight)

Blue-native gel electrophoresis:

• Extract mitochondrial membrane proteins using 0.08% DDM

• Load 10 μg of mitochondrial-enriched protein per lane

• For two-dimensional analysis, cut lanes from blue-native gels and run them in a second dimension on SDS-PAGE

Immunocytochemistry:

• Standard fixation protocols are suitable (paraformaldehyde-based)

• Include mitochondrial markers for co-localization studies

• Use 1:50-1:200 dilution of primary antibody

How can NDUFA4 antibodies be used to study disease-associated mitochondrial dysfunction?

NDUFA4 antibodies can be valuable tools for investigating mitochondrial dysfunction in various diseases:

• COX deficiency disorders: NDUFA4 mutations cause COX deficiency linked to neurological disorders. Antibodies can help detect reduced or absent NDUFA4 protein in patient samples .

• Cancer metabolism studies: NDUFA4 has been implicated in promoting glycolysis and mitochondrial fission in gastric cancer. Antibodies can measure expression levels and correlate with disease progression .

• Mitochondrial complex assembly: Blue-native gel electrophoresis with NDUFA4 antibodies can reveal assembly defects in complex IV. Research has shown that the COX enzyme complex without NDUFA4 is detectable with no abnormal subassemblies in patient muscle .

• Oxidative stress studies: NDUFA4 has been shown to regulate ROS levels and mitochondrial membrane potential. Antibodies combined with functional assays can help understand the relationship between NDUFA4 expression and oxidative stress .

How can I design experiments to investigate the relationship between NDUFA4 and mitochondrial complex assembly?

To study NDUFA4's role in mitochondrial complex assembly:

• Blue-native polyacrylamide gel electrophoresis (BN-PAGE):

  • Use low detergent conditions (≤0.08% DDM) for mitochondrial protein extraction

  • Perform both one- and two-dimensional BN-PAGE analysis

  • Probe with antibodies against NDUFA4 and established complex IV subunits (e.g., MTCO1/MTCO2)

  • This approach has revealed that complex IV holoenzyme is present even in the absence of NDUFA4, suggesting it's not required for assembly but for function

• In-gel activity staining:

  • Perform BN-PAGE followed by in-gel activity staining for complex IV

  • Compare activity between samples with normal and deficient NDUFA4 levels

  • Research has shown reduced complex IV activity in muscle tissue of patients with NDUFA4 mutations

• Co-immunoprecipitation:

  • Use NDUFA4 antibodies for immunoprecipitation

  • Analyze co-precipitated proteins by mass spectrometry or western blot

  • This can identify direct interaction partners of NDUFA4 in the complex

What approaches can resolve contradictory findings regarding NDUFA4's complex association?

To address the historical contradiction regarding NDUFA4's association with complex I versus complex IV:

• Detergent titration experiments:

  • Perform western blot analysis of blue-native gels with mitochondrial proteins extracted using serial dilutions of DDM (from 0.01% to 2%)

  • Probe with antibodies against NDUFA4, complex I markers (e.g., NDUFA9), and complex IV markers (e.g., MTCO1)

  • Research has shown that NDUFA4 migrates with complex IV at low detergent concentrations but dissociates at higher concentrations

• Cross-linking studies:

  • Perform protein cross-linking before extraction to stabilize native complexes

  • Analyze by BN-PAGE and western blot with antibodies against NDUFA4 and subunits of complexes I and IV

• Comparative analysis:

  • Two-dimensional BN-PAGE can reveal that NDUFA4 and complex I subunits (like NDUFA9) migrate separately

  • Research has demonstrated NDUFA9 appearing as a double spot in samples from patients with NDUFA4 mutations, distinct from the NDUFA4 migration pattern

How can NDUFA4 antibodies contribute to understanding post-translational regulations of mitochondrial function?

Recent research has revealed important post-translational regulatory mechanisms:

• m6A RNA methylation:

  • NDUFA4 expression can be regulated by m6A RNA methylation

  • The methyltransferase METTL3 increases m6A levels of NDUFA4 mRNA via the m6A reader IGF2BP1

  • This promotes NDUFA4 expression in gastric cancer cells

  • Antibodies can be used to measure NDUFA4 protein levels after manipulation of the m6A pathway

• Mitochondrial dynamics studies:

  • NDUFA4 has been shown to promote glycolytic and oxidative metabolism in cancer cells

  • It inhibits ROS levels and promotes mitochondrial membrane potential

  • These functions can be assessed using NDUFA4 antibodies in combination with functional assays for mitochondrial respiration and glycolysis

• Experimental design approach:

  • Manipulate NDUFA4 expression (knockdown/overexpression)

  • Measure changes in mitochondrial function (respiration, membrane potential)

  • Correlate with cellular phenotypes (proliferation, apoptosis)

  • Use NDUFA4 antibodies to confirm expression changes and localization

What methodological considerations are important when studying NDUFA4 in patients with mitochondrial disorders?

When investigating NDUFA4 in clinical samples:

• Sample types:

  • Muscle tissue is typically used for diagnosing mitochondrial disorders

  • Cultured skin fibroblasts can also be valuable and less invasive

  • Research has successfully used both sample types to study NDUFA4 defects

• Enzyme activity measurements:

  • Spectrophotometric analysis of respiratory chain enzymes

  • In-gel activity staining of blue-native gels

  • Both methods have confirmed reduced complex IV activity in NDUFA4-deficient samples

• Genetic analysis considerations:

  • NDUFA4 mutations can affect splicing (e.g., the c.42+1G→C mutation)

  • RT-PCR analysis can detect aberrant transcripts

  • Western blot with NDUFA4 antibodies can confirm protein loss

How can I design experiments to investigate NDUFA4's role in neuronal function and neurological disorders?

NDUFA4 has been implicated in neurological disorders, and experimental approaches include:

• Knockout mouse models:

  • NDUFA4 knockout mice have been generated by targeting exons 3 and 4

  • Genotyping primers and validation methods are available in the literature

  • These models can be used to study neuronal phenotypes

• Neuronal function studies:

  • Assess neuronal proliferation and apoptosis in relation to NDUFA4 expression

  • Investigate microRNA regulation of NDUFA4 in neurons

  • NDUFA4 antibodies can confirm protein expression in different neural cell types

• Patient-derived samples:

  • COX-deficient Leigh syndrome has been linked to NDUFA4 mutations

  • NDUFA4 antibodies can detect protein loss in patient samples

  • Immunocytochemistry has demonstrated absent NDUFA4 protein with normal mitochondrially encoded COX subunits

By employing these methodological approaches, researchers can advance understanding of NDUFA4's role in mitochondrial function and associated diseases, potentially leading to new therapeutic strategies for mitochondrial disorders.